Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer

Anti-estrogen and anti-HER2 treatments have been among the first and most successful examples of targeted therapy for breast cancer (BC). However, the treatment of triple-negative BC (TNBC) that lack estrogen receptor expression or HER2 amplification remains a major challenge. We previously discover...

Descripción completa

Detalles Bibliográficos
Autores principales: Thakkar, A., Wang, B., Picon-Ruiz, M., Buchwald, P., Ince, Tan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Preclinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869778/
https://www.ncbi.nlm.nih.gov/pubmed/27120467
http://dx.doi.org/10.1007/s10549-016-3807-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869778/
https://www.ncbi.nlm.nih.gov/pubmed/27120467
http://dx.doi.org/10.1007/s10549-016-3807-y

Ejemplares similares